TY - JOUR
T1 - Gastric lymphatic flows may change before and after endoscopic submucosal dissection
T2 - in vivo porcine survival models
AU - Nohara, Kyoko
AU - Goto, Osamu
AU - Takeuchi, Hiroya
AU - Sasaki, Motoki
AU - Maehata, Tadateru
AU - Yahagi, Naohisa
AU - Kitagawa, Yuko
N1 - Funding Information:
Funding This study was partly supported by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology in Japan in 2015–2017 (Grant No. 15K09061).
Publisher Copyright:
© 2019, The International Gastric Cancer Association and The Japanese Gastric Cancer Association.
PY - 2019/7/12
Y1 - 2019/7/12
N2 - Background and study aim: Standard gastrectomy with lymphadenectomy is recommended following endoscopic submucosal dissection (ESD) due to the risk of lymph-node metastasis for resected cancers. However, when lymphatic flows remain unchanged after ESD, a minimally invasive function-preserving surgery based on the sentinel node (SN) concept may be applicable. In this study, using porcine survival models, we aimed to investigate whether gastric lymphatic flows were modified following ESD. Methods: Twelve pigs, each with one simulating lesion 3 cm in size, were used. Indocyanine green (ICG) fluid was endoscopically injected into the submucosa in four quadrants surrounding the lesion. Following laparoscopic observation of lymphatic flows, the lesions were resected by ESD. After 4 weeks, ICG fluid was injected in four quadrants surrounding the scar and lymphatic flows were observed in the same manner as the initial procedure. The distribution of lymphatic flows, including stained SNs, was compared. Results: In ten lesions (83.3%), the distribution of flows remained unchanged. However, in one lesion, the flow along the right gastric epiploic artery (R-GEA) disappeared on the lesser curvature of the middle stomach. In addition, in one lesion, the flow along R-GEA emerged on the lesser curvature of the lower stomach. Conclusions: Our study revealed that, despite ESD, lymphatic flows remained unchanged in most parts of the stomach. The SN concept may be applied after ESD, except for lesions on the lesser curvature. However, in the case of the lesser curvature, special care must be given to the SN concept.
AB - Background and study aim: Standard gastrectomy with lymphadenectomy is recommended following endoscopic submucosal dissection (ESD) due to the risk of lymph-node metastasis for resected cancers. However, when lymphatic flows remain unchanged after ESD, a minimally invasive function-preserving surgery based on the sentinel node (SN) concept may be applicable. In this study, using porcine survival models, we aimed to investigate whether gastric lymphatic flows were modified following ESD. Methods: Twelve pigs, each with one simulating lesion 3 cm in size, were used. Indocyanine green (ICG) fluid was endoscopically injected into the submucosa in four quadrants surrounding the lesion. Following laparoscopic observation of lymphatic flows, the lesions were resected by ESD. After 4 weeks, ICG fluid was injected in four quadrants surrounding the scar and lymphatic flows were observed in the same manner as the initial procedure. The distribution of lymphatic flows, including stained SNs, was compared. Results: In ten lesions (83.3%), the distribution of flows remained unchanged. However, in one lesion, the flow along the right gastric epiploic artery (R-GEA) disappeared on the lesser curvature of the middle stomach. In addition, in one lesion, the flow along R-GEA emerged on the lesser curvature of the lower stomach. Conclusions: Our study revealed that, despite ESD, lymphatic flows remained unchanged in most parts of the stomach. The SN concept may be applied after ESD, except for lesions on the lesser curvature. However, in the case of the lesser curvature, special care must be given to the SN concept.
KW - Early gastric cancer
KW - Endoscopic submucosal dissection
KW - Sentinel lymph node
UR - http://www.scopus.com/inward/record.url?scp=85059567615&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059567615&partnerID=8YFLogxK
U2 - 10.1007/s10120-018-00920-w
DO - 10.1007/s10120-018-00920-w
M3 - Article
C2 - 30603912
AN - SCOPUS:85059567615
SN - 1436-3291
VL - 22
SP - 723
EP - 730
JO - Gastric Cancer
JF - Gastric Cancer
IS - 4
ER -